Jaguar Health Reports Third Quarter 2026 Financials
Jaguar's rare disease intestinal failure development program for microvillus inclusion disease (MVID) and short bowel syndrome for crofelemer powder for oral solution is expected to continue to provide clinical milestones, including a planned New …
Weiterlesen »